$DXCM DEXCOM INC Insider Trading Week 10/2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in DEXCOM INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in DEXCOM INC in week 10/2015.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 13 2015 | DXCM | DEXCOM INC | MOY JEFFREY | SVP, Operations | Gift | G | 0.00 | 450 | 0 | 168,811 | 169.3 K to 168.8 K (-0.27 %) |
| Mar 13 2015 | DXCM | DEXCOM INC | MOY JEFFREY | SVP, Operations | Sell | D | 58.58 | 4,448 | 260,547 | 169,261 | 173.7 K to 169.3 K (-2.56 %) |
| Mar 13 2015 | DXCM | DEXCOM INC | MOY JEFFREY | SVP, Operations | Buy | J | 59.91 | 8,333 | 499,230 | 173,709 | 165.4 K to 173.7 K (+5.04 %) |
| Mar 13 2015 | DXCM | DEXCOM INC | MOY JEFFREY | SVP, Operations | Sell | D | 58.74 | 8,824 | 518,324 | 165,376 | 174.2 K to 165.4 K (-5.07 %) |
| Mar 13 2015 | DXCM | DEXCOM INC | MOY JEFFREY | SVP, Operations | Sell | D | 58.74 | 3,861 | 226,796 | 174,200 | 178.1 K to 174.2 K (-2.17 %) |
| Mar 13 2015 | DXCM | DEXCOM INC | MOY JEFFREY | SVP, Operations | Sell | J | 59.91 | 8,333 | 499,230 | 90,000 | 98.3 K to 90 K (-8.47 %) |
| Mar 13 2015 | DXCM | DEXCOM INC | SKYLER JAY S | Director | Option Exercise | M | 21.81 | 10,000 | 218,100 | 0 | |
| Mar 13 2015 | DXCM | DEXCOM INC | SKYLER JAY S | Director | Option Exercise | M | 20.38 | 6,500 | 132,470 | 0 | |
| Mar 13 2015 | DXCM | DEXCOM INC | SKYLER JAY S | Director | Option Exercise | M | 20.38 | 3,500 | 71,330 | 6,500 | |
| Mar 13 2015 | DXCM | DEXCOM INC | SKYLER JAY S | Director | Option Exercise | M | 12.00 | 3,436 | 41,232 | 0 | |
| Mar 13 2015 | DXCM | DEXCOM INC | SKYLER JAY S | Director | Option Exercise | M | 12.00 | 21,564 | 258,768 | 3,436 | |
| Mar 13 2015 | DXCM | DEXCOM INC | SKYLER JAY S | Director | Sell | S | 60.01 | 10,000 | 600,142 | 115,884 | 125.9 K to 115.9 K (-7.94 %) |
| Mar 13 2015 | DXCM | DEXCOM INC | SKYLER JAY S | Director | Buy | M | 21.81 | 10,000 | 218,100 | 125,884 | 115.9 K to 125.9 K (+8.63 %) |
| Mar 13 2015 | DXCM | DEXCOM INC | SKYLER JAY S | Director | Sell | S | 60.01 | 6,500 | 390,092 | 115,884 | 122.4 K to 115.9 K (-5.31 %) |
| Mar 13 2015 | DXCM | DEXCOM INC | SKYLER JAY S | Director | Buy | M | 20.38 | 6,500 | 132,470 | 122,384 | 115.9 K to 122.4 K (+5.61 %) |
| Mar 13 2015 | DXCM | DEXCOM INC | SKYLER JAY S | Director | Sell | S | 60.00 | 3,500 | 210,000 | 115,884 | 119.4 K to 115.9 K (-2.93 %) |
| Mar 13 2015 | DXCM | DEXCOM INC | SKYLER JAY S | Director | Buy | M | 20.38 | 3,500 | 71,330 | 119,384 | 115.9 K to 119.4 K (+3.02 %) |
| Mar 13 2015 | DXCM | DEXCOM INC | SKYLER JAY S | Director | Sell | S | 60.00 | 3,436 | 206,160 | 115,884 | 119.3 K to 115.9 K (-2.88 %) |
| Mar 13 2015 | DXCM | DEXCOM INC | SKYLER JAY S | Director | Buy | M | 12.00 | 3,436 | 41,232 | 119,320 | 115.9 K to 119.3 K (+2.97 %) |
| Mar 13 2015 | DXCM | DEXCOM INC | SKYLER JAY S | Director | Sell | S | 60.00 | 21,564 | 1,293,903 | 115,884 | 137.4 K to 115.9 K (-15.69 %) |
| Mar 13 2015 | DXCM | DEXCOM INC | SKYLER JAY S | Director | Buy | M | 12.00 | 21,564 | 258,768 | 137,448 | 115.9 K to 137.4 K (+18.61 %) |
| Mar 13 2015 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical, Regu ... | Option Exercise | M | 9.80 | 7,500 | 73,500 | 50,573 | |
| Mar 13 2015 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical, Regu ... | Sell | D | 58.58 | 4,448 | 260,548 | 179,741 | 184.2 K to 179.7 K (-2.41 %) |
| Mar 13 2015 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical, Regu ... | Sell | S | 58.58 | 7,500 | 439,367 | 184,189 | 191.7 K to 184.2 K (-3.91 %) |
| Mar 13 2015 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical, Regu ... | Buy | M | 9.80 | 7,500 | 73,500 | 191,689 | 184.2 K to 191.7 K (+4.07 %) |
| Mar 13 2015 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical, Regu ... | Sell | D | 58.74 | 8,824 | 518,324 | 184,189 | 193 K to 184.2 K (-4.57 %) |
| Mar 13 2015 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical, Regu ... | Sell | D | 58.74 | 4,743 | 278,605 | 193,013 | 197.8 K to 193 K (-2.40 %) |
| Mar 13 2015 | DXCM | DEXCOM INC | DOUBLEDAY RICHARD | EVP, Chief Commerci ... | Option Exercise | M | 9.80 | 17,500 | 171,500 | 988 | |
| Mar 13 2015 | DXCM | DEXCOM INC | DOUBLEDAY RICHARD | EVP, Chief Commerci ... | Option Exercise | M | 9.80 | 2,500 | 24,500 | 12 | |
| Mar 13 2015 | DXCM | DEXCOM INC | DOUBLEDAY RICHARD | EVP, Chief Commerci ... | Sell | S | 58.94 | 2,500 | 147,358 | 153,826 | 156.3 K to 153.8 K (-1.60 %) |
| Mar 13 2015 | DXCM | DEXCOM INC | DOUBLEDAY RICHARD | EVP, Chief Commerci ... | Buy | M | 9.80 | 2,500 | 24,500 | 156,326 | 153.8 K to 156.3 K (+1.63 %) |
| Mar 13 2015 | DXCM | DEXCOM INC | DOUBLEDAY RICHARD | EVP, Chief Commerci ... | Sell | S | 59.28 | 17,500 | 1,037,320 | 153,826 | 171.3 K to 153.8 K (-10.21 %) |
| Mar 13 2015 | DXCM | DEXCOM INC | DOUBLEDAY RICHARD | EVP, Chief Commerci ... | Buy | M | 9.80 | 17,500 | 171,500 | 171,326 | 153.8 K to 171.3 K (+11.38 %) |
| Mar 13 2015 | DXCM | DEXCOM INC | DOUBLEDAY RICHARD | EVP, Chief Commerci ... | Sell | D | 58.58 | 4,448 | 260,549 | 153,826 | 158.3 K to 153.8 K (-2.81 %) |
| Mar 13 2015 | DXCM | DEXCOM INC | DOUBLEDAY RICHARD | EVP, Chief Commerci ... | Sell | D | 58.74 | 8,121 | 477,029 | 158,274 | 166.4 K to 158.3 K (-4.88 %) |
| Mar 13 2015 | DXCM | DEXCOM INC | DOUBLEDAY RICHARD | EVP, Chief Commerci ... | Sell | D | 58.74 | 1,629 | 95,688 | 166,395 | 168 K to 166.4 K (-0.97 %) |
| Mar 13 2015 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Sell | S | 59.78 | 11,138 | 665,833 | 79,191 | 90.3 K to 79.2 K (-12.33 %) |
| Mar 13 2015 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Sell | D | 58.58 | 6,371 | 373,191 | 90,329 | 96.7 K to 90.3 K (-6.59 %) |
| Mar 13 2015 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Buy | J | 59.91 | 11,937 | 715,146 | 96,700 | 84.8 K to 96.7 K (+14.08 %) |
| Mar 13 2015 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Sell | D | 58.74 | 12,529 | 735,956 | 84,763 | 97.3 K to 84.8 K (-12.88 %) |
| Mar 13 2015 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Sell | D | 58.74 | 5,357 | 314,671 | 97,292 | 102.6 K to 97.3 K (-5.22 %) |
| Mar 13 2015 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Sell | J | 59.91 | 11,937 | 715,146 | 116,207 | 128.1 K to 116.2 K (-9.32 %) |
| Mar 13 2015 | DXCM | DEXCOM INC | LISTER JOHN | Sr. VP, General Cou ... | Sell | D | 58.58 | 3,114 | 182,407 | 131,094 | 134.2 K to 131.1 K (-2.32 %) |
| Mar 13 2015 | DXCM | DEXCOM INC | LISTER JOHN | Sr. VP, General Cou ... | Sell | D | 58.74 | 11,205 | 658,184 | 134,208 | 145.4 K to 134.2 K (-7.71 %) |
| Mar 13 2015 | DXCM | DEXCOM INC | LISTER JOHN | Sr. VP, General Cou ... | Sell | D | 58.74 | 2,105 | 123,648 | 145,413 | 147.5 K to 145.4 K (-1.43 %) |
| Mar 13 2015 | DXCM | DEXCOM INC | ROPER JESS | SVP, CFO | Sell | D | 58.58 | 2,669 | 156,341 | 111,483 | 114.2 K to 111.5 K (-2.34 %) |
| Mar 13 2015 | DXCM | DEXCOM INC | ROPER JESS | SVP, CFO | Sell | D | 58.74 | 5,031 | 295,522 | 114,152 | 119.2 K to 114.2 K (-4.22 %) |
| Mar 13 2015 | DXCM | DEXCOM INC | ROPER JESS | SVP, CFO | Sell | D | 58.74 | 1,629 | 95,688 | 119,183 | 120.8 K to 119.2 K (-1.35 %) |
| Mar 13 2015 | DXCM | DEXCOM INC | Pacelli Steven Robert | EVP, Strategy & Cor ... | Sell | D | 58.58 | 6,371 | 373,189 | 248,646 | 255 K to 248.6 K (-2.50 %) |
| Mar 13 2015 | DXCM | DEXCOM INC | Pacelli Steven Robert | EVP, Strategy & Cor ... | Sell | D | 58.74 | 12,529 | 735,956 | 255,017 | 267.5 K to 255 K (-4.68 %) |
| Mar 13 2015 | DXCM | DEXCOM INC | Pacelli Steven Robert | EVP, Strategy & Cor ... | Sell | D | 58.74 | 6,320 | 371,238 | 267,546 | 273.9 K to 267.5 K (-2.31 %) |
| Mar 13 2015 | DXCM | DEXCOM INC | SAYER KEVIN R | President & CEO | Sell | D | 58.58 | 13,343 | 781,592 | 432,360 | 445.7 K to 432.4 K (-2.99 %) |
| Mar 13 2015 | DXCM | DEXCOM INC | SAYER KEVIN R | President & CEO | Sell | D | 58.74 | 26,469 | 1,554,794 | 445,703 | 472.2 K to 445.7 K (-5.61 %) |
| Mar 13 2015 | DXCM | DEXCOM INC | SAYER KEVIN R | President & CEO | Sell | D | 58.74 | 8,680 | 509,865 | 472,172 | 480.9 K to 472.2 K (-1.81 %) |
| Mar 11 2015 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Option Exercise | M | 13.45 | 8,244 | 110,882 | 24,731 | |
| Mar 11 2015 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Sell | S | 59.87 | 926 | 55,440 | 102,649 | 103.6 K to 102.6 K (-0.89 %) |
| Mar 11 2015 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Sell | S | 59.24 | 5,712 | 338,405 | 103,575 | 109.3 K to 103.6 K (-5.23 %) |
| Mar 11 2015 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Buy | J | 59.59 | 23,667 | 1,410,317 | 109,287 | 85.6 K to 109.3 K (+27.64 %) |
| Mar 11 2015 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Buy | J | 59.59 | 11,937 | 711,326 | 85,620 | 73.7 K to 85.6 K (+16.20 %) |
| Mar 11 2015 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Sell | S | 58.77 | 8,244 | 484,529 | 128,144 | 136.4 K to 128.1 K (-6.04 %) |
| Mar 11 2015 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Buy | M | 13.45 | 8,244 | 110,882 | 136,388 | 128.1 K to 136.4 K (+6.43 %) |
| Mar 11 2015 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Sell | J | 59.59 | 23,667 | 1,410,317 | 128,144 | 151.8 K to 128.1 K (-15.59 %) |
| Mar 11 2015 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Sell | J | 59.59 | 11,937 | 711,326 | 151,811 | 163.7 K to 151.8 K (-7.29 %) |
| Mar 11 2015 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Grant | A | 0.00 | 45,000 | 45 | 163,748 | 118.7 K to 163.7 K (+37.90 %) |
| Mar 11 2015 | DXCM | DEXCOM INC | Pacelli Steven Robert | EVP, Strategy & Cor ... | Grant | A | 0.00 | 45,000 | 45 | 273,866 | 228.9 K to 273.9 K (+19.66 %) |
| Mar 10 2015 | DXCM | DEXCOM INC | MOY JEFFREY | SVP, Operations | Buy | J | 59.59 | 16,667 | 993,187 | 178,061 | 161.4 K to 178.1 K (+10.33 %) |
| Mar 10 2015 | DXCM | DEXCOM INC | MOY JEFFREY | SVP, Operations | Buy | J | 59.59 | 7,292 | 434,530 | 161,394 | 154.1 K to 161.4 K (+4.73 %) |
| Mar 10 2015 | DXCM | DEXCOM INC | MOY JEFFREY | SVP, Operations | Sell | J | 59.59 | 16,667 | 993,187 | 98,333 | 115 K to 98.3 K (-14.49 %) |
| Mar 10 2015 | DXCM | DEXCOM INC | MOY JEFFREY | SVP, Operations | Sell | J | 59.59 | 7,292 | 434,530 | 115,000 | 122.3 K to 115 K (-5.96 %) |
| Mar 10 2015 | DXCM | DEXCOM INC | MOY JEFFREY | SVP, Operations | Grant | A | 0.00 | 40,000 | 40 | 122,292 | 82.3 K to 122.3 K (+48.61 %) |
| Mar 10 2015 | DXCM | DEXCOM INC | ROPER JESS | SVP, CFO | Grant | A | 0.00 | 40,000 | 40 | 120,812 | 80.8 K to 120.8 K (+49.50 %) |
| Mar 10 2015 | DXCM | DEXCOM INC | DOUBLEDAY RICHARD | EVP, Chief Commerci ... | Grant | A | 0.00 | 47,500 | 48 | 168,024 | 120.5 K to 168 K (+39.41 %) |
| Mar 10 2015 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical, Regu ... | Grant | A | 0.00 | 47,500 | 48 | 197,756 | 150.3 K to 197.8 K (+31.61 %) |
| Mar 10 2015 | DXCM | DEXCOM INC | GREGG TERRANCE H | Director | Grant | A | 0.00 | 35,000 | 35 | 430,626 | 395.6 K to 430.6 K (+8.85 %) |
| Mar 10 2015 | DXCM | DEXCOM INC | SAYER KEVIN R | President & CEO | Grant | A | 0.00 | 90,000 | 90 | 480,852 | 390.9 K to 480.9 K (+23.03 %) |
| Mar 10 2015 | DXCM | DEXCOM INC | LISTER JOHN | Sr. VP, General Cou ... | Option Exercise | M | 8.85 | 5,039 | 44,595 | 7,435 | |
| Mar 10 2015 | DXCM | DEXCOM INC | LISTER JOHN | Sr. VP, General Cou ... | Sell | S | 58.77 | 5,039 | 296,156 | 147,518 | 152.6 K to 147.5 K (-3.30 %) |
| Mar 10 2015 | DXCM | DEXCOM INC | LISTER JOHN | Sr. VP, General Cou ... | Buy | M | 8.85 | 5,039 | 44,595 | 152,557 | 147.5 K to 152.6 K (+3.42 %) |
| Mar 10 2015 | DXCM | DEXCOM INC | LISTER JOHN | Sr. VP, General Cou ... | Grant | A | 0.00 | 37,500 | 38 | 147,518 | 110 K to 147.5 K (+34.09 %) |
| Mar 09 2015 | DXCM | DEXCOM INC | KAHN BARBARA | Director | Sell | S | 60.29 | 3,000 | 180,873 | 46,525 | 49.5 K to 46.5 K (-6.06 %) |